MaxCyte
MXCT on XNAS, MaxCyte, Inc.
Measures activity, not value. Not investment advice.
Shares sold short (30 Oct 2026)
1.6M
-14% vs the report before
Short interest, % of shares outstanding
1.5%
103.3M shares outstanding (6 Nov 2026)
Days to cover
1.3
short interest / daily volume
Short sale volume share (20 Nov 2026)
11%
1-year median 26%
Sharp changes
10
short interest spike
FINRA short interest by settlement date (the 15th and the last business day of each month). FINRA publishes each report 7 business days after its settlement date. Dashed: 3-year median.
See the numbers
| 30 Oct 2026: 1.6M shares sold short, 1.3 days to cover |
| 15 Oct 2026: 1.8M shares sold short, 1.1 days to cover |
| 30 Sep 2026: 1.1M shares sold short, 3.1 days to cover |
| 15 Sep 2026: 1.2M shares sold short, 2.8 days to cover |
| 31 Aug 2026: 1.3M shares sold short, 2.4 days to cover |
| 14 Aug 2026: 1.2M shares sold short, 1.1 days to cover |
| 31 Jul 2026: 1.2M shares sold short, 1.6 days to cover |
| 15 Jul 2026: 1.4M shares sold short, 1.2 days to cover |
| 30 Jun 2026: 1.5M shares sold short, 1.0 days to cover |
| 15 Jun 2026: 4.2M shares sold short, 5.8 days to cover |
| 29 May 2026: 4.5M shares sold short, 3.8 days to cover |
| 15 May 2026: 4.7M shares sold short, 3.8 days to cover |
| 30 Apr 2026: 5.2M shares sold short, 8.2 days to cover |
| 15 Apr 2026: 5.4M shares sold short, 6.4 days to cover |
| 31 Mar 2026: 5.6M shares sold short, 5.8 days to cover |
| 13 Mar 2026: 5.5M shares sold short, 5.0 days to cover |
| 27 Feb 2026: 5.8M shares sold short, 5.2 days to cover |
| 13 Feb 2026: 5.1M shares sold short, 3.0 days to cover |
| 30 Jan 2026: 3.9M shares sold short, 3.5 days to cover |
| 15 Jan 2026: 2.5M shares sold short, 4.0 days to cover |
| 31 Dec 2025: 2.4M shares sold short, 4.0 days to cover |
| 15 Dec 2025: 2.7M shares sold short, 1.4 days to cover |
| 28 Nov 2025: 2.8M shares sold short, 2.6 days to cover |
| 14 Nov 2025: 3.0M shares sold short, 3.8 days to cover |
| 31 Oct 2025: 3.0M shares sold short, 6.1 days to cover |
| 15 Oct 2025: 3.4M shares sold short, 5.2 days to cover |
| 30 Sep 2025: 3.2M shares sold short, 3.3 days to cover |
| 15 Sep 2025: 3.5M shares sold short, 6.6 days to cover |
| 29 Aug 2025: 3.3M shares sold short, 3.1 days to cover |
| 15 Aug 2025: 3.6M shares sold short, 2.8 days to cover |
| 31 Jul 2025: 3.5M shares sold short, 8.3 days to cover |
| 15 Jul 2025: 3.5M shares sold short, 7.3 days to cover |
| 30 Jun 2025: 3.4M shares sold short, 3.9 days to cover |
| 13 Jun 2025: 3.6M shares sold short, 4.2 days to cover |
| 30 May 2025: 3.5M shares sold short, 2.6 days to cover |
| 15 May 2025: 3.8M shares sold short, 3.4 days to cover |
| 30 Apr 2025: 3.5M shares sold short, 5.6 days to cover |
| 15 Apr 2025: 3.5M shares sold short, 4.8 days to cover |
| 31 Mar 2025: 3.3M shares sold short, 5.8 days to cover |
| 14 Mar 2025: 3.0M shares sold short, 3.3 days to cover |
| 28 Feb 2025: 2.7M shares sold short, 5.2 days to cover |
| 14 Feb 2025: 2.8M shares sold short, 7.5 days to cover |
| 31 Jan 2025: 2.7M shares sold short, 4.1 days to cover |
| 15 Jan 2025: 3.0M shares sold short, 4.6 days to cover |
| 31 Dec 2024: 3.1M shares sold short, 7.4 days to cover |
| 13 Dec 2024: 3.2M shares sold short, 5.6 days to cover |
| 29 Nov 2024: 3.1M shares sold short, 3.6 days to cover |
| 15 Nov 2024: 3.3M shares sold short, 4.3 days to cover |
| 31 Oct 2024: 3.2M shares sold short, 13.2 days to cover |
| 15 Oct 2024: 3.5M shares sold short, 11.4 days to cover |
| 30 Sep 2024: 3.9M shares sold short, 10.6 days to cover |
| 13 Sep 2024: 3.8M shares sold short, 13.5 days to cover |
| 30 Aug 2024: 3.8M shares sold short, 11.7 days to cover |
| 15 Aug 2024: 3.8M shares sold short, 9.8 days to cover |
| 31 Jul 2024: 3.9M shares sold short, 10.5 days to cover |
| 15 Jul 2024: 4.2M shares sold short, 7.8 days to cover |
| 28 Jun 2024: 4.1M shares sold short, 4.8 days to cover |
| 14 Jun 2024: 3.4M shares sold short, 6.4 days to cover |
| 31 May 2024: 3.7M shares sold short, 12.4 days to cover |
| 15 May 2024: 3.5M shares sold short, 5.2 days to cover |
What the numbers say
- 1.6M shares sold short on 30 Oct 2026, 1.5% of shares outstanding, 1.3 days to cover; -14% on the report before (published by FINRA on 10 Nov 2026).
Every measure from this source
Short interest is a position, reported twice a month. Short sale volume is a different measure: the share of each day's trading on off-exchange venues that was a short sale. Market makers sell short routinely, so 40% to 50% is normal.
Sharp changes
10 in all loaded history, strongest first
MaxCyte had 5.8M shares sold short in the 27 Feb 2026 report, 2.1× the same report last year.
Same report last year: 2.7M; its normal report is 3.4M.
See the evidence
- This period
- 5.8M (the 27 Feb 2026 report)
- Normal report (median of 24 earlier)
- 3.4M
- Typical spread (median absolute deviation)
- 185K
- How far from its usual level
- +6.7
- Same report last year
- 2.7M
- History used
- 1,659 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
MaxCyte had 5.6M shares sold short in the 31 Mar 2026 report, 1.7× the same report last year.
Same report last year: 3.3M; its normal report is 3.5M.
See the evidence
- This period
- 5.6M (the 31 Mar 2026 report)
- Normal report (median of 24 earlier)
- 3.5M
- Typical spread (median absolute deviation)
- 218K
- How far from its usual level
- +6.0
- Same report last year
- 3.3M
- History used
- 1,691 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
MaxCyte had 5.5M shares sold short in the 13 Mar 2026 report, 1.8× the same report last year.
Same report last year: 3.0M; its normal report is 3.5M.
See the evidence
- This period
- 5.5M (the 13 Mar 2026 report)
- Normal report (median of 24 earlier)
- 3.5M
- Typical spread (median absolute deviation)
- 196K
- How far from its usual level
- +5.9
- Same report last year
- 3.0M
- History used
- 1,673 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
MaxCyte had 4.0M shares sold short in the 15 Dec 2023 report, 2.3× the same report last year.
Same report last year: 1.8M; its normal report is 2.1M.
See the evidence
- This period
- 4.0M (the 15 Dec 2023 report)
- Normal report (median of 24 earlier)
- 2.1M
- Typical spread (median absolute deviation)
- 235K
- How far from its usual level
- +5.5
- Same report last year
- 1.8M
- History used
- 854 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
MaxCyte had 5.1M shares sold short in the 13 Feb 2026 report, 1.8× the same report last year.
Same report last year: 2.8M; its normal report is 3.4M.
See the evidence
- This period
- 5.1M (the 13 Feb 2026 report)
- Normal report (median of 24 earlier)
- 3.4M
- Typical spread (median absolute deviation)
- 221K
- How far from its usual level
- +5.1
- Same report last year
- 2.8M
- History used
- 1,645 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
MaxCyte had 4.0M shares sold short in the 29 Dec 2023 report, 2.1× the same report last year.
Same report last year: 1.9M; its normal report is 2.2M.
See the evidence
- This period
- 4.0M (the 29 Dec 2023 report)
- Normal report (median of 24 earlier)
- 2.2M
- Typical spread (median absolute deviation)
- 245K
- How far from its usual level
- +5.1
- Same report last year
- 1.9M
- History used
- 868 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.